Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathy.
Fujisawa F, Kunimasa K, Kano-Fujiwara R, Sato Y, Kusama H, Nishio M, Matsui S, Yoshinami T, Kittaka N, Nakamura H, Nagata S, Honma K, Yagi T, Nakayama T, Tamaki Y, Imamura F. Fujisawa F, et al. Among authors: honma k. Breast Cancer. 2021 May;28(3):765-771. doi: 10.1007/s12282-020-01200-1. Epub 2021 Jan 2. Breast Cancer. 2021. PMID: 33389615
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y, Kukita Y, Kitamura M, Kurashige M, Masaie H, Fuji S, Ishikawa J, Honma K, Wakasa T, Hanamoto H, Hirokawa M, Suzuki A, Morii E, Nakatsuka SI. Hamamoto Y, et al. Among authors: honma k. Histopathology. 2021 Oct;79(4):521-532. doi: 10.1111/his.14378. Epub 2021 Aug 3. Histopathology. 2021. PMID: 33829512
Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib.
Kunimasa K, Nishino K, Kukita Y, Matsumoto S, Kawachi H, Kawamura T, Inoue T, Tamiya M, Honma K, Sugimoto N, Yamasaki T, Imamura F, Goto K, Kumagai T. Kunimasa K, et al. Among authors: honma k. Cancer Genet. 2021 Aug;256-257:57-61. doi: 10.1016/j.cancergen.2021.04.001. Epub 2021 Apr 10. Cancer Genet. 2021. PMID: 33901930
EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors.
Kunimasa K, Hirotsu Y, Kukita Y, Ueda Y, Sato Y, Kimura M, Otsuka T, Hamamoto Y, Tamiya M, Inoue T, Kawamura T, Nishino K, Amemiya K, Goto T, Mochizuki H, Honma K, Omata M, Kumagai T. Kunimasa K, et al. Among authors: honma k. Cancer Genet. 2021 Aug;256-257:131-135. doi: 10.1016/j.cancergen.2021.05.010. Epub 2021 May 28. Cancer Genet. 2021. PMID: 34130229
816 results